Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
1,997
Value
$114.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,997$114.3K<0.1%+229+13.0%AddedHolders
Q1 20261,768$99.9K<0.1%+448+33.9%AddedHolders
Q4 20251,320$78.4K<0.1%+551+71.7%AddedHolders
Q3 2025769$41.6K<0.1%+295+62.2%AddedHolders
Q2 2025474$26.0K<0.1%−861−64.5%ReducedHolders
Q1 20251,335$94.4K<0.1%+660+97.8%AddedHolders
Q4 2024675$44.4K<0.1%−395−36.9%ReducedHolders
Q3 20241,070$75.2K<0.1%−1,064−49.9%ReducedHolders
Q2 20242,134$175.7K<0.1%−233−9.8%ReducedHolders
Q1 20242,367$206.7K<0.1%+169+7.7%AddedHolders
Q4 20232,198$211.9K<0.1%−154−6.5%ReducedHolders
Q3 20232,352$208.1K<0.1%−3,062−56.6%ReducedHolders
Q2 20235,414$469.3K<0.1%−604−10.0%ReducedHolders
Q1 20236,018$585.2K<0.1%+1,046+21.0%AddedHolders
Q4 20224,972$514.6K<0.1%+439+9.7%AddedHolders
Q3 20224,533$384.0K<0.1%+3,289+264.4%AddedHolders
Q2 20221,244$103.0K<0.1%+29+2.4%AddedHolders
Q1 20221,215$95.0K<0.1%−262−17.7%ReducedHolders
Q4 20211,477$130.0K<0.1%+750+103.2%AddedHolders
Q3 2021727$56.0K<0.1%+32+4.6%AddedHolders
Q2 2021695$58.0K<0.1%+117+20.2%AddedHolders
Q1 2021578$44.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.